Helicobacter pylori-associated immune thrombocytopenia

Platelets

Volumn 17, Issue 2, 2006, Pages 71-77

  Franchini, Massimo ^a,c   Veneri, Dino ^b  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c OSPEDALE POLICLINICO   (Italy)

Author keywords

Heliobacter pylori; Therapy; Thrombocytopenia

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AUTOANTIBODY; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; STEROID;

AUTOIMMUNE DISEASE; CELL DESTRUCTION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EVALUATION; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFECTION; INFECTION CONTROL; LYMPHOPROLIFERATIVE DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOCYTE COUNT;

ANTI-BACTERIAL AGENTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 31544473502     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100500438057     Document Type: Review

References (71)

1. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. New Engl J Med 2002;346:995-1008.
2. British Society for Haematology. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003;120:574-596.
3. Provan D, Newland A. Fifty years of idiopathic thrombocytopenic purpura (ITP): Management of refractory ITP in adults. Br J Haematol 2002;118:933-944.
4. McCrae KR, Bussel JB, Mannucci PM, Remuzzi G, Cines DB. Platelets: An update on diagnosis and management of thrombocytopenic disorders. Hematology (Am Soc Hematol Educ Program) 2001;1:282-305.
5. Franchini M, Veneri D. Helicobacter pylori infection and immune thrombocytopenic purpura: An update. Helicobacter 2004;9:342-346.
6. Fujimura K. Helicobacter pylori infection and idiopathic thrombocytopenic purpura. Int J Hematol 2005;81:113-118.
7. Emilia G, Luppi M, Torelli G. Infectious agents and human immune diseases: Lessons from Helicobacter pylori. Am J Med 2005;118:420-421.
8. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;i:1311-1315.
9. Graham DY. Treatment of peptic ulcers caused by Helicobacter pylori. New Engl J Med 1993;328:349-350.
10. Suerbaum S, Michetti P. Helicobacter pylori infection. New Engl J Med 2002;347:1175-1186.
11. Parsonnet J, Hansen S, Rodriguez I, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori infection and gastric lymphoma. New Engl J Med 1994;330:1267-1271.
12. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. Regression of primary low-grade B-cell gastric lymphoma of mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-577.
13. Isaacson PG, Spencer J. Is gastric lymphoma an infectious disease? Hum Pathol 1993;24:569-570.
14. Ambinder R. Infection and lymphoma. New Engl J Med 2003:349:1309-1311.
15. Tsang KW, Lam SK. Helicobacter pylori and extra-digestive diseases. J Gastroenterol Hepatol 1999;14:844-850.
16. Gasbarrini A, Carloni E, Gasbarrini G, Ménard A. Helicobacter pylori and extragastric diseases - Other Helicobacters. Helicobacter 2003;8(Suppl. 1):68-76.
17. De Luis DA, Varela C, de la Calle H. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol 1998;26:259-263.
18. Gupta V, Eden AJ, Mills MJ. Helicobacter pylori and autoimmune neutropenia. Clin Lab Haematol 2002;24:183-185.
19. Gasbarrini A, Franceschi F. Autoimmune diseases and Helicobacter pylori infection. Biomed Pharmacother 1999;53:223-226.
20. Franchini M, Veneri D. Helicobacter pylori infection and immune thrombocytopenic purpura. Haematologica 2003;88:1087-1091.
21. Huber MR, Kumar S, Tefferi A. Treatment advances in adult immune thrombocytopenic purpura. Ann Hematol 2003;82:723-727.
22. Kurtoglu E, Kayacetin E, Ugur A. Helicobacter pylori infection in patients with autoimmune thrombocytopenic purpura. World J Gastroenterol 2004;10:2113-2115.
23. Jackson S, Beck PL, Pineo GF, Poon MC. Helicobacter pylori eradication: Novel therapy for immune thrombocytopenic purpura? A review of the literature. Am J Hematol 2005;78:142-150.
24. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998;352:878.
25. Emilia G, Longo G, Luppi M, Gandini G, Morselli M, Ferrara L, Amarri S, Cagossi K, Torelli G. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 2001;97:812-814.
26. Jarque I, Andreu R, Llopis I, De la Rubia J, Gomis F, Senent L, Jimenez C, Martin G, Martinez JA, Sanz GF, Ponce J, Sanz MA. Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol 2001;115:1002-1003.
27. Veneri D, Franchini M, Gottardi M, D'Adda M, Ambrosetti A, Krampera M, Zanetti F, Pizzolo G. Efficacy of Helicobacter pylori eradication in enhancing platelet count in adult patients with idiopathic thrombocytopenic purpura. Haematologica 2002;87:1777-1779.
28. Kohda K, Kuga T, Kogawa K, Kanisawa Y, Koike K, Kuroiwa G, Hirayama Y, Sato Y, Niitsu Y. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol 2002;118:584-588.
29. Hino M, Yamane T, Park K, Takubo T, Ohta K, Kitagawa S, Higuchi K, Arakawa T. Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura. Ann Hematol 2003;82:30-32.
30. Hashino S, Mori A, Suzuki S, Izumiyama K, Kahata K, Yonezumi M, Chiba K, Kondo T, Ota S, Toyashima N, Kato N, Tanaka J, Imamura M, Asaka M. Platelet recovery in patients with idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori. Int J Hematol 2003;77:188-191.
31. Ando K, Shimamoto T, Tauchi T, Ito Y, Kuryiama Y, Gotoh A. Can eradication therapy for Helicobacter pylori really improve the thromocytopenia in idiopathic thrombocytopenic purpura? Our experience and literature review. Int J Hematol 2003;77:239-244.
32. Michel M, Cooper N, Jean C, Frissora C, Bussel JB. Does Helicobacter pylori initiate or perpetuate immune thrombocytopenic purpura? Blood 2004;103:890-896.
33. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, Okubo M, Zaitsu Y, Ariyoshi K, Nakamura Y, Nawata R, Oka Y, Shirai M, Tanizawa Y. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol 2004;124:91-96.
34. Sato R, Murakami K, Watanabe K, Okimoto T, Miyajima H, Ogata M, Ohtsuka E, Kodama M, Saburi Y, Fujioka T, Nasu M. Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Arch Intern Med 2004;164:1904-1907.
35. Ando T, Tsuzuki T, Mizuno T, Minami M, Ina K, Kusugami K, Takamatsu J, Adachi K, El-Omar E, Ohta M, Goto H. Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura. Helicobacter 2004;9:443-452.
36. Nomura S, Inami N, Kanazawa S. The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura. Eur J Haematol 2004;72:304-305.
37. Fujimura K, Kuwana M, Kurata Y, Imamura M, Harada H, Sakamaki H, Teramura M, Koda K, Nomura S, Sugihara S, Shimomura T, Fujimoto TT, Oyashiki K, Ikeda Y. Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol 2005;81:162-168.
38. Veneri V, Krampera M, Franchini M. High prevalence of sustained remission of idiopathic thrombocytopenic purpura after Helicobacter pylori eradication: A long-term follow-up study. Platelets 2005;16:117-119.
39. Stasi R, Rossi Z, Stipa E, Amadori S, Newland AC, Provan D. Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med 2005;118:414-419.
40. Garcia Perez A, Valverde de La Osa J, Gimenez Samper M, Alonso Garcia I. Resolution of an autoimmune thrombocytopenic purpura after eradication treatment of Helicobacter pylori. Sangre 1999;44:387-388.
41. Grimaz S, Damiani D, Brosolo P, Skert C, Geromin A, de Pretis G. Resolution of thrombocytopenia after treatment for Helicobacter pylori: A case report. Haematologica 1999;84:283-284.
42. Tohda S, Ohkusa T. Resolution of refractory idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori. Am J Hematol 2000;65:329-330.
43. Soldinger E, Pilia MC, Piubello W, Nadali G. Multi-resistant idiopathic thrombocytopenia successfully treated by eradication of Helicobacter pylori. Dig Liv Dis 2001;33:732.
44. Emilia G, Luppi M, Morselli M, Potenza L, D'Apollo N, Torelli G. Helicobacter pylori infection and idiopathic thrombocytopenic purpura. Br J Haematol 2002;118:1198-1199.
45. Mukai M, Kon Y, Notoya A, Kohno M. Helicobacter pylori associated with idiopathic thrombocytopenic purpura. Am J Med 2002;113:169-171.
46. Michel M, Khellfar M, Desforges L, Lee K, Schaeffer A, Godeau B, Bierling B. Autoimmune thrombocytopenic purpura and Helicobacter pylori infection. Arch Intern Med 2002;162:1033-1036.
47. Veneri D, Krampera M, Franchini M. Helicobacter pylori infection and idiopathic thrombocytopenic purpura: Description of 21 newly diagnosed cases. Haematologica 2004 Apr;89(4):ECR08.
48. Morselli M, Potenza L, Luppi M, Torelli G, Emilia G. Immune thrombocytopenic purpura and Helicobacter pylori infection. Arch Intern Med 2003;163:120.
49. Franchini M, Krampera M, Veneri D. Helicobacter pylori eradication in adults with idiopathic thrombocytopenic purpura. Am J Med 2003;114:420-421.
50. Marchi S, Bellini M, Costa F, De Bortoli N, Petrini M, Maltinti G. Thrombocytopenic purpura: An unusual complication of eradication therapy for Helicobacter pylori. Digest Liv Dis 2002;34:665-667.
51. Katelaris PH, Tippett GH, Norbu P, Lowe DG, Brennan R, Farthing MJ. Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India. Gut 1992;33:1462-1466.
52. Lane JA, Harvey RF, Murray LJ, Harvey IM, Donovan JL, Nair P, Egger M. A placebo-controlled randomized trial of eradication of Helicobacter pylori in the general population: Study design and response rates of the Bristol Helicobacter Project. Control Clin Trials 2002;23:321-332.
53. Russo A, Eboli M, Pizzetti P, Di Felice G, Ravagnini F, Spinelli P. Determination of Helicobacter pylori seroprevalence among Italian blood donors. Eur J Gastroenterol Hepatol 1999;11:867-873.
54. Graham DY, Malaty HM, Evans DG, Evans Jr DJ, Klein PD, Adam E. Epidemiology of Helicobacter pylori in a asymptomatic population in the United States. Effect of age, race and socioeconomic status. Gastroenterology 1991;100:1495-1501.
55. Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis 2000;181:1359-1363.
56. Rajantie J, Klemola T. Helicobacter pylori and idiopathic thrombocytopenic purpura in children. Blood 2003;101:1660.
57. Lamarque D, Peek Jr RM. Pathogenesis of Helicobacter pylori infection. Helicobacter 2003;8(Suppl. 1):21-30.
58. Bettaieb A, Fromont P, Louache F, Oksenhendler E, Vainchenker W, Duedari N, Bierling P. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. Blood 1992;80:162-169.
59. Bettaieb A, Oksenhendler E, Duedari N, Bierling P. Cross-reactive antibodies between HIV-gp120 and platelet gpIIIa (CD61) in HIV-related immune thrombocytopenic purpura. Clin Exp Immunol 1996;103:19-23.
60. Ko GH, Park HB, Shin MK, Park CK, Lee JH, Youn HS, Cho MJ, Lee WK, Rhee KH. Monoclonal antibodies against Helicobacter pylori cross-react with human tissue. Helicobacter 1997;2:210-215.
61. Veneri D, Gottardi M, Guizzardi E, Zanuso C, Krampera M, Franchini M. Idiopathic thombocytopenic purpura, Helicobacter pylori infection and HLA class II alleles. Blood 2002;100:1926-1927.
62. Veneri D, de Matteis G, Solero P, Federici F, Zanuso C, Guizzardi E, Arena S, Gaio M, Pontiero P, Ricetti MM, Franchini M. Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: Correlation with Helicobacter pylori infection and response to eradication treatment. Platelets 2005;16:307-311.
63. Byrne MF, Kerrogan SW, Corcoran PA, Atherton JC, Murray FE, Fitzgerald DJ, Cox DM. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology 2003;124:1846-1854.
64. Roark JH, Bussel JB, Cines DB, Siegel DL. Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation. Blood 2002;100:1388-1398.
65. Akiyama H, Onozawa Y. Effect of omeprazole in chronic idiopathic thrombocytopenic purpura. Am J Hematol 1998;57:91-92.
66. Takahashi T, Yujiri T, Tanizawa Y. Helicobacter pylori and chronic ITP: The discrepancy in the clinical responses to eradication therapy might be due to differences in the bacterial strains. Blood 2004;104:594.
67. Kumagai T, Sekigawa K, Hashimoto N, Shirato R. Remission of idiopathic thrombocytopenic purpura by eradicating Helicobacter pylori after omeprazole monotherapy. Int J Hematol 2001;74:237-238.
68. Fukuda Y. Suppression of H. pylori colonization with omeprazole. Scand J Gastroenterol 1996;31(Suppl 214): 54-55.
69. Ohguchi H, Kameoka J, Harigae H, Yamada M, Tomiya Y, Takahashi S, Ishizawa K, Sano N, Sekine H, Sasaki T. Can the Helicobacter pylori eradication regimen induce platelet recovery in H. pylori-negative patients with idiopathic thrombocytopenic purpura? Am J Hematol 2005;78:164-165.
70. Jaing TH, Yang CP, Hung IJ, Chiu CH, Chang KW. Efficacy of Helicobacter pylori eradication on platelet recovery in children with chronic idiopathic thrombocytopenic purpura. Acta Paediatr 2003;92:1153-1157.
71. Kurekci AE, Atay AA, Sarici SU, Ozcan O. Complete platelet recovery after treatment of Helicobacter pylori infection in a child with chronic immune thrombocytopenic purpura: A case report. Pediatr Hematol Oncol 2004;21:593-596.